Abstract
A method for evaluation of interferon (IFN) preparations for clinical trials is presented. IFN produced by human lymphoblastoid cells, undergoes strict quality control and safety tests, based on the U.S. Food and Drug Administration (FDA) recommendations. According to the results obtained, the IFN preparation meets the standards for use in man.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
